Lesabelimab Antibody
Lesabelimab (LDP) is a human IgG1κ monoclonal antibody targeting the CD274 (PD-L1) immune checkpoint protein. By blocking PD-L1's interaction with PD-1, it reactivates T-cell-mediated antitumor immunity, supporting its use in both in vitro cellular assays and in vivo oncology research models.
Product Specifications
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
6.14 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AM1933 2 OD, 4 OD, 50 OD
MIRacle™ hsa-miR-6799-5p miRNA Agomir/Antagomir
Sign In for Pricing
View Details 
MBS141486-01 0.05 mg
Recombinant Rhesus Macaque BCA-1/ BLC (CXCL13)
Sign In for Pricing
View Details